BridgeMD
New treatment option for Adolescent Development
Official title Inspiratory and Expiratory Muscle Training in Adolescent Volleyball Players
ClinicalTrials.gov ID: NCT06759779
What this study is testing
- What it's testing
- This study will investigate the effects of inspiratory and expiratory muscle training on respiratory muscle strength, pulmonary function, and performance status in adolescent athletes
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 12 to 18, women only. Healthy volunteers may be eligible.
You may be able to join if
- Athletes aged 12-18 who train at a submaximal level at least 3 days a week
You likely can't join if
- Adolescents with any history of chronic lung disease
- unable to comply with the test and training
- unwilling to participate in the study
The study team makes the final eligibility decision.
Where it's taking place
- Ankara, Emek, Turkey (Türkiye)
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 12 years to 18 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Ankara, Emek, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.